Biotech News 20 Feb 2025 Blood Test Predicts How Long Vaccines Will Protect You How long will vaccine protection last? A simple blood test may have the answer. Researchers at Stanford School of Medicine,… Pantitra
Biotech News 17 Feb 2025 Groundbreaking advances in tuberculosis vaccine development and therapies Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually. In a comprehensive review… Pantitra
Biotech News 17 Jan 2025 Discovery could eliminate need to refrigerate vaccines and protein-based drugs A new storage technique can keep protein-based drugs and vaccines stable without keeping them cold. The discovery, led by… Pantitra
BioNet News 17 Jan 2025 BioNet Wins BARDA Patch Forward Prize for Microneedle mRNA Vaccine Innovation Lyon, France & Bangkok, Thailand – January 17, 2025 – BioNet, a global leader in vaccine innovation, proudly announces its… Supachai
BioNet News 15 Jan 2025 LTS and BioNet Win U.S. BARDA Patch Forward Prize Competition Andernach – LTS, a leading pharmaceutical technology company, and BioNet, a biotech manufacturer specializing in genetically engineered vaccines, announced today… Supachai
BioNet News 03 Jan 2025 BioNet’s Support for Local Communities BioNet recently teamed up with the Social Development and Human Security Office of Ayutthaya, and local volunteers to visit vulnerable… Supachai
BioNet News 31 Dec 2024 A reduced-dose recombinant pertussis vaccine booster in Thai adolescents: a phase 2/3, observer-blinded, randomised controlled, non-inferiority trial Pertussis, also known as whooping cough, is an acute respiratory disease caused by Bordetella pertussis, a bacterium that is transmitted between… Pantitra
BioNet News 30 Dec 2024 Pertussis Immunity 5 Years After Booster Vaccination With Recombinant Pertussis Vaccines Pertussis remains one of the least controlled vaccine-preventable diseases. Pertussis booster vaccines are associated with fast-waning immunity and offer only… Pantitra
Biotech News 11 Dec 2024 Needle-Free: New Nano-Vaccine Effective Against All COVID-19 Variants A new nano-vaccine developed by TAU and the University of Lisbon offers a needle-free, room-temperature-storable solution against COVID-19, targeting all key… Pantitra
Biotech News 27 Nov 2024 Innovating LNP design to improve mRNA therapeutics The new approach involving refinement and optimisation of ionisable lipids could accelerate the development of mRNA therapies, research suggests. A… Pantitra
